Type I Diabetes Clinical Trial
Official title:
Developmental Influences on Management of Type I Diabetes
This 1-year study will explore the influences of family and peers on how diabetic adolescents
manage their disease, focusing on adolescent developmental transitions. The management of
diabetes is a complex process involving daily self-care activities, problem-solving, and
decision-making. It is particularly challenging during adolescence when youth are
experiencing physiological, social and psychological changes, and coming under increasing
peer influence and decreasing parental supervision. Although it is expected that the
responsibility for diabetes management will gradually shift from the parent to the child
during adolescence, research indicates that many children may be given responsibility for
managing their illness too early, without adequate parental monitoring. Specifically, this
study will examine the following issues:
- The relationship of peers, parents and school support to successful diabetes management;
- The influence of the adolescent's self-image and personal goals on diabetes management;
- The influence of the adolescent's and parents' attitudes, capability and environment on
the balance of responsibility for diabetes management.
Children between 10 and 16 years of age receiving treatment for diabetes type 1 at Georgetown
University Medical Center's pediatric diabetes clinic may be eligible for this study. The
children must have been diagnosed with diabetes at least 1 year before entering the study and
must require insulin treatment. One parent of each child will also participate in the study.
Children and their parents will complete the following procedures:
Home Interviews: Parents and children will complete two at-home face-to-face interviews 6
months apart. At each interview, children will answer questions about their responsibility
for and adherence to their diabetes management, treatment outcome expectations, optimism,
self-esteem, self-consciousness, personal goals, social support, perceived barriers to
diabetes management, family routine and family conflict, their parents' involvement in their
diabetes management, and parenting style. Parents will evaluate their child's ability to
manage his or her diabetes, level of maturity, self-esteem, and transition of responsibility;
their family routine and family conflict, parent-child communication, their parenting goals,
and their involvement in and responsibility for their child's diabetes management. Three days
after the 6-month interview, a randomly selected group of parents and children will complete
a brief, additional telephone interview covering some of the same issues.
Telephone Interview: At 12 months, parents and children will complete a telephone interview
that will include questions about adherence to diabetes management and the responsibility of
parents and children for diabetes management.
Management of diabetes is a complex process involving the conduct of daily self-care activities, problem-solving, and decision-making. It is particularly challenging during adolescence when youth are experiencing a variety of physiological, social, and psychological changes at the same time that they are taking increased responsibility for their own diabetes care. This study examines the influence of family, social, and adolescent developmental transitions. Over the course of 12 months, a sample of 135 parent-child dyads will provide information on individual efficacy, maturity, family and social support, attitudes toward diabetes management, and diabetes management behaviors. One goal of this pilot study is to identify factors that predict the adherence of individual youth and parents during this transition period. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05160142 -
Diabetes Inspired Culinary Education
|
Early Phase 1 | |
Withdrawn |
NCT05035368 -
Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT01928329 -
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
|
Phase 2 | |
Completed |
NCT02127762 -
The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy
|
N/A | |
Completed |
NCT00999375 -
Cultivating Healthy Environments in Families With Type 1 Diabetes (CHEF)
|
Phase 2 | |
Completed |
NCT04279613 -
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
|
Phase 1 | |
Not yet recruiting |
NCT02117518 -
Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients
|
N/A | |
Withdrawn |
NCT01477476 -
Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
|
Phase 2 | |
Terminated |
NCT01308437 -
Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics
|
Phase 3 | |
Terminated |
NCT01652911 -
A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT06242548 -
How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude
|
N/A | |
Completed |
NCT00351650 -
Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan
|
N/A | |
Withdrawn |
NCT00361608 -
Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device
|
N/A | |
Terminated |
NCT03653533 -
Evaluation of the Function "Stop Before Hypoglycemia" on External Insulin Pump
|
N/A | |
Completed |
NCT02002130 -
The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
|
Phase 1 | |
Completed |
NCT02634216 -
Effects of Capros in Patients With Type-1 Diabetes
|
N/A | |
Withdrawn |
NCT01623388 -
Epigenetic Modifications of Diabetes Mellitus Type I
|
N/A | |
Completed |
NCT02612493 -
Obesity and Metabolic Surgery in Patients With Type I Diabetes
|
N/A | |
Completed |
NCT01843114 -
Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects
|
N/A | |
Withdrawn |
NCT01398670 -
Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics
|
Phase 3 |